SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: i-node who wrote (164682)5/19/2020 11:59:42 AM
From: Lane31 Recommendation

Recommended By
J_F_Shepard

  Read Replies (1) of 361518
 
>> We absolutely do not routinely conduct trials that require both experimental and control group to be purposely exposed to something potentially damaging, even deadly.

We're still talking about Hydroxychloroquine, right? One of the top prescribed 100 or so drugs in the world for the last 50 years?


Try to keep up.

That drug has long since been accepted for the treatment of malaria and lupus. It seems to have been determined to be safe enough for that purpose although posing some risk to some people. I am not here challenging the safety of hydroxychloroquine so you are wasting your time and mine defending it.

What's on the table here is a notion taken from your Dr Z and chewed upon by me that using it as a universal prophylactic could obviate or at least reduce the need for a covid vaccine. That's a big idea.

The purposeful exposure that I spoke to, then, is to covid, not hydroxychorolquine. To prove that your drug prevents infection by covid you'd not only have to give your drug to the experimental group, then you'd have to give all the trial participants, both groups, a dose of potentially damaging/deadly covid.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News